228 related articles for article (PubMed ID: 24478433)
1. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.
Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES
J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433
[TBL] [Abstract][Full Text] [Related]
2. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
Tso FY; West JT; Wood C
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
[TBL] [Abstract][Full Text] [Related]
3. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.
Lu J; Verma SC; Cai Q; Robertson ES
J Virol; 2011 Jul; 85(13):6148-61. PubMed ID: 21507979
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters.
Izumiya Y; Algalil A; Espera JM; Miura H; Izumiya C; Inagaki T; Kumar A
J Virol; 2024 Feb; 98(2):e0138623. PubMed ID: 38240593
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus (KSHV) LANA prevents KSHV episomes from degradation.
Nakajima K-i; Inagaki T; Espera JM; Izumiya Y
J Virol; 2024 Feb; 98(2):e0126823. PubMed ID: 38240588
[TBL] [Abstract][Full Text] [Related]
6. Primary B Lymphocytes Infected with Kaposi's Sarcoma-Associated Herpesvirus Can Be Expanded In Vitro and Are Recognized by LANA-Specific CD4+ T Cells.
Nicol SM; Sabbah S; Brulois KF; Jung JU; Bell AI; Hislop AD
J Virol; 2016 Apr; 90(8):3849-3859. PubMed ID: 26819313
[TBL] [Abstract][Full Text] [Related]
7. Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription.
Lu F; Day L; Gao SJ; Lieberman PM
J Virol; 2006 Jun; 80(11):5273-82. PubMed ID: 16699007
[TBL] [Abstract][Full Text] [Related]
8. Single molecule analysis of replicated DNA reveals the usage of multiple KSHV genome regions for latent replication.
Verma SC; Lu J; Cai Q; Kosiyatrakul S; McDowell ME; Schildkraut CL; Robertson ES
PLoS Pathog; 2011 Nov; 7(11):e1002365. PubMed ID: 22072974
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
Paul AG; Chandran B; Sharma-Walia N
Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment.
Singh VV; Dutta D; Ansari MA; Dutta S; Chandran B
J Virol; 2014 Mar; 88(5):2821-34. PubMed ID: 24352470
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma herpesvirus latency-associated nuclear antigen broadly regulates viral gene expression and is essential for lytic infection.
Li S; Wang M; Van Sciver N; Szymula A; Tumuluri VS; George A; Ramachandran A; Raina K; Costa CN; Zhao B; Kazemian M; Simas JP; Kaye KM
PLoS Pathog; 2024 Jan; 20(1):e1011907. PubMed ID: 38232124
[TBL] [Abstract][Full Text] [Related]
12. Reversible switching of primary cells between normal and malignant state by oncogenic virus KSHV and CRISPR/Cas9-mediated targeting of a major viral latent protein.
Ju E; Li T; Ramos da Silva S; Markazi A; Gao SJ
J Med Virol; 2021 Aug; 93(8):5065-5075. PubMed ID: 33942339
[TBL] [Abstract][Full Text] [Related]
13. A CRISPR-Cas9 screen identifies mitochondrial translation as an essential process in latent KSHV infection of human endothelial cells.
Holmes DL; Vogt DT; Lagunoff M
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28384-28392. PubMed ID: 33122441
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Developing Treatments of Kaposi's Sarcoma Herpesvirus-Related Diseases.
Naimo E; Zischke J; Schulz TF
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578378
[TBL] [Abstract][Full Text] [Related]
15. Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA.
Ye X; Guerin LN; Chen Z; Rajendren S; Dunker W; Zhao Y; Zhang R; Hodges E; Karijolich J
Cell Rep; 2024 Mar; 43(3):113888. PubMed ID: 38416644
[TBL] [Abstract][Full Text] [Related]
16. Proteomic profiling identifies the SIM-associated complex of KSHV-encoded LANA.
Gan J; Wang C; Jin Y; Guo Y; Xu F; Zhu Q; Ding L; Shang H; Wang J; Wei F; Cai Q; Robertson ES
Proteomics; 2015 Jun; 15(12):2023-37. PubMed ID: 25894481
[TBL] [Abstract][Full Text] [Related]
17. Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins.
Chen W; Sin SH; Wen KW; Damania B; Dittmer DP
PLoS Pathog; 2012; 8(11):e1003048. PubMed ID: 23209418
[TBL] [Abstract][Full Text] [Related]
18. Targeting the Kaposi's sarcoma-associated herpesvirus genome with the CRISPR-Cas9 platform in latently infected cells.
Haddad CO; Kalt I; Shovman Y; Xia L; Schlesinger Y; Sarid R; Parnas O
Virol J; 2021 Mar; 18(1):56. PubMed ID: 33731154
[TBL] [Abstract][Full Text] [Related]
19. Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus.
Lu C; Zeng Y; Huang Z; Huang L; Qian C; Tang G; Qin D
Am J Pathol; 2005 Jan; 166(1):173-83. PubMed ID: 15632010
[TBL] [Abstract][Full Text] [Related]
20. Elevated iNOS and 3'-nitrotyrosine in Kaposi's Sarcoma tumors and mouse model.
Vladimirova O; Soldan S; Su C; Kossenkov A; Ngalamika O; Tso FY; West JT; Wood C; Lieberman PM
Tumour Virus Res; 2023 Jun; 15():200259. PubMed ID: 36863485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
